Related Experiment Video
Updated: Jun 5, 2025

Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus MRSA in Rat
Published on: June 4, 2012
Serratia marcescens Prosthetic Valve Endocarditis: Portending a Dismal Course
Selma Siagh1, Najlaa Belharty1, Hasna Rami1
1Department of Cardiology B, Ibn Sina Hospital, Rabat, MAR.
Serratia marcescens infective endocarditis (IE) is rare but deadly, especially in prosthetic valve patients. This case highlights the need for better diagnostic and therapeutic strategies for this challenging infection.
Area of Science:
- Infectious Diseases
- Cardiology
- Critical Care Medicine
Background:
- Serratia marcescens is an opportunistic pathogen frequently associated with healthcare-associated infections.
- Infective endocarditis (IE) caused by S. marcescens is uncommon and associated with higher mortality rates than typical IE pathogens.
Observation:
- A 70-year-old male with a recent mitral valve replacement presented with early prosthetic valve endocarditis.
- The patient experienced high-grade fever and clinical deterioration, leading to the diagnosis of S. marcescens IE.
Findings:
- Despite treatment with ertapenem and surgical intervention, the patient's prognosis remained unfavorable.
- This case underscores the aggressive nature and poor outcomes associated with S. marcescens IE.
Implications:
- Further research into S. marcescens IE is crucial for developing effective prevention and treatment guidelines.
- Special attention is needed for managing prosthetic valve endocarditis caused by this pathogen to improve patient outcomes.
Related Concept Videos
Endocarditis III: Medical Management
Endocarditis I: Introduction
Mitral Valve Prolapse II: Assessment and Management
Endocarditis II: Clinical features and Diagnostic Tests
Mitral Stenosis I: Introduction
Endocarditis IV: Nursing Management

